Roche: The technology digitises tissue samples, allowing them to be viewed and analysed remotely. July 21, 2025 Egypt - Roche Diagnostics is supporting Egypt’s expansion of digital pathology and the integration of artificial intelligence...

Roche: Information platform empowers the public with knowledge on latest cancer treatment technologies According to data from the Hong Kong Cancer Registry of the Hospital Authority, the overall five-year survival rate for cancer patients has...

Results from Phase IIb PADOVA and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody,...

Roche plans to invest as much as $550 million in its Indianapolis diagnostics campus during the next five years, with plans to build it into a U.S. manufacturing and distribution hub for its wearable diabetes blood sugar sensors. The announced...

The Roche VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment.  The device uses artificial intelligence-based image analysis with a...

AUSTIN, Texas (March 27, 2025) – Clinical laboratory and pathology executives from many of the nation’s most-prominent clinical labs will come together on April 28-30, 2025 in New Orleans, LA, to celebrate the 30th anniversary the...